Phase I/II trial of vandetanib in children and adolescents with hereditary medullary thyroid carcinoma

被引：0
|
作者：
Fox, E.
Widemann, B. C.
Whitcomb, P. O.
Aikin, A.
Dombi, E.
Lodish, M.
Stratakis, C. A.
Steinberg, S.
Wells, S. A., Jr.
Balis, F. M.
机构：
[1] NCI, Bethesda, MD 20892 USA
[2] NICHD, Bethesda, MD USA
[3] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10014
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [31] Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy
    Lodish, Maya
    Gkourogianni, Alexandra
    Bornstein, Ethan
    Sinaii, Ninet
    Fox, Elizabeth
    Chuk, Meredith
    Marcus, Leigh
    Akshintala, Srivandana
    Balis, Frank
    Widemann, Brigitte
    Stratakis, Constantine A.
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2015,
  • [32] Management of patients with hereditary medullary thyroid carcinoma
    Fitze, G
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2004, 14 (06) : 375 - 383
  • [33] Molecular diagnostics of hereditary medullary thyroid carcinoma
    Ziemnicka, Katarzyna
    Kaczmarek, Marta
    Hoppe-Golebiewska, Justyna
    Slomski, Ryszard
    Sowinski, Jerzy
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2005, 9 (04): : 175 - 177
  • [34] Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma
    Cosimo Durante
    Alessandra Paciaroni
    Katia Plasmati
    Fabiana Trulli
    Sebastiano Filetti
    Endocrine, 2013, 44 : 334 - 342
  • [35] Hereditary medullary thyroid carcinoma: the management dilemma
    Ping Zhou
    Jian Liu
    Shao-Wen Cheng
    Bing Wang
    Rong Yang
    Ling Peng
    Familial Cancer, 2012, 11 : 157 - 165
  • [36] RADIOIODINE IN THE TREATMENT OF HEREDITARY MEDULLARY CARCINOMA OF THE THYROID
    KRUSEMAN, ACN
    BUSSEMAKER, JK
    FROLICH, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (03): : 491 - 494
  • [37] Hereditary medullary thyroid carcinoma: the management dilemma
    Zhou, Ping
    Liu, Jian
    Cheng, Shao-Wen
    Wang, Bing
    Yang, Rong
    Peng, Ling
    FAMILIAL CANCER, 2012, 11 (02) : 157 - 165
  • [38] MEDULLARY CARCINOMA OF THYROID AND PHEOCHROMOCYTOMA - A HEREDITARY SYNDROME
    LJUNGBER.O
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1966, 67 (04): : 589 - &
  • [39] MANAGEMENT OF HEREDITARY MEDULLARY-THYROID CARCINOMA
    BAYLIN, SB
    WELLS, SA
    CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1981, 10 (02): : 367 - 378
  • [40] Results of a pretargeted radioimmunotherapy (RIT) phase I/II trial in medullary thyroid carcinoma (MTC): Biological markers and effects on survival
    Barbet, J
    Kraeber-Bodere, F
    Campion, L
    Chatal, JF
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (04) : 523 - 523
12345